New York Assembly Bill 6475: Requires health insurance policies to cover comprehensive genetic screening and FDA approved biomarker testing for ovarian and prostate cancers.

New York · 2025-2026 session

What it does

Requires health insurance policies to cover comprehensive genetic screening and FDA approved biomarker testing for ovarian and prostate cancers.

referred to insurance (2026-01-07)